5 results match your criteria: "Texas Tech University Health Sciences Center at Lubbock[Affiliation]"

Background: Myocardial injury has been described in coronavirus-2019 (COVID-19). Few studies have reported cardiovascular imaging data with transthoracic echocardiography (TTE) and electrocardiography (ECG) findings in COVID-19 patients, and their correlation with mortality.

Methods: We conducted a retrospective cohort study that included COVID-19 patients from March 2020 through February 2021 who had TTE and ECG during hospital admission.

View Article and Find Full Text PDF

To assess the prevalence of psychiatric disorders among children and adolescents in child welfare custody admitted to the hospital. Data were collected from the 2016-2017 National Inpatient Sample of the US population of general hospital admissions. Data for patients aged 12-17 years who were in child welfare custody were obtained using the diagnosis code Z6221: child in welfare custody.

View Article and Find Full Text PDF

Pyo-pericardium is a collection of purulent fluid in the pericardial sac. It is a rare finding seen in less than 1% of patients who develop acute pericarditis. The condition, though uncommon, has a mortality risk of 100% in untreated patients and 40% in treated patients.

View Article and Find Full Text PDF

Objective: The prognostic value of changes in neutrophil-to-lymphocyte ratios (NLR) in cardiac arrest survivors receiving targeted temperature management (TTM) is unknown. The current study investigated NLR in postcardiac arrest (PCA) patients undergoing TTM.

Methods: This retrospective single-center study included 95 patients (59 males, age: 55.

View Article and Find Full Text PDF

The Role of MicroRNAs in Breast Cancer.

J Assoc Genet Technol

July 2011

Molecular Pathology, Dept of Laboratory Sciences and Primary Care, Texas Tech University Health Sciences Center at Lubbock, TX.

Breast cancer is the most common form of cancer in women. Despite extensive study, the etiology of breast cancer remains ambiguous. A group of genetic modifiers known as microRNAs (miRNAs) are emerging onto the scene of breast cancer research.

View Article and Find Full Text PDF